Overview

Location [1]
4q21.23
Synonyms [1]
ABRA1, CCDC98

FAM175A is altered in 0.41% of all cancers with colon adenocarcinoma, lung adenocarcinoma, bladder urothelial carcinoma, prostate adenocarcinoma, and conventional glioblastoma multiforme having the greatest prevalence of alterations [3].

FAM175A GENIE Cases - Top Diseases

The most common alterations in FAM175A are FAM175A Mutation (0.28%), FAM175A Loss (0.03%), FAM175A Amplification (0.03%), FAM175A N303Ifs*17 (0.01%), and FAM175A D352E (0.00%) [3].

FAM175A GENIE Cases - Top Alterations

Significance of FAM175A in Diseases

Malignant Solid Tumor +

Prostate Adenocarcinoma +

Cholangiocarcinoma +

Clear Cell Renal Cell Carcinoma +

Mesothelioma +

Uveal Melanoma +

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.